Physician profile
Sydney L Adams
NPI 1952923914
$621.53
in general payments reported to CMS, 2019-2025
14 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $197 · 2023: $203 · 2024: $54.66 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $120.63 | 2022-2023 | Briviact |
| Medtronic, INC. | $120.07 | 2022 | |
| Microvention, INC. | $52.93 | 2023-2024 | Eric Retrieval Device, Stent |
| Davol INC. | $52.63 | 2025 | |
| Abbvie INC. | $42.64 | 2023-2025 | Ubrelvy, Qulipta |
| Orthofix Medical, INC. | $37.57 | 2024-2025 | Spinal-Stim, Cervical-Stim |
| Merz Pharmaceuticals, LLC | $30.52 | 2025 | Xeomin |
| Astrazeneca Pharmaceuticals LP | $30.02 | 2023-2024 | Andexxa |
| Depuy Synthes Sales INC. | $26.81 | 2023 | Viper |
| Bioventus LLC | $25.28 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.42 | 2022 | |
| Cordis US Corp. | $23.01 | 2025 | Precise Pro Rx |
| Lilly USA, LLC | $19.41 | 2025 | Kisunla |
| Globus Medical, INC. | $15.59 | 2023 | Quartex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.